Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Dishman Carbogen Amcis Ltd. ( (IN:DCAL) ) has provided an announcement.
Dishman Carbogen Amcis Limited has announced a conference call with investors scheduled for November 5, 2025, to discuss the company’s financial results and performance for the quarter and half-year ended September 30, 2025. This announcement is part of the company’s ongoing efforts to maintain transparency with stakeholders and provide insights into its financial health and strategic direction.
More about Dishman Carbogen Amcis Ltd.
Established in 1983, Dishman Carbogen Amcis Limited is a fully integrated Contract Development and Manufacturing Organisation (CDMO) with a global presence. The company specializes in process research, development, and the manufacturing and supply of Active Pharmaceutical Ingredients (APIs) to innovator pharmaceutical companies. Their comprehensive product offerings include high-value niche CDMO services, APIs, High Potent APIs, Intermediates, Phase Transfer Catalysts, Vitamin D Analogues, Cholesterol, Lanolin-related products, and Antiseptic and Disinfectant formulations.
Average Trading Volume: 21,203
Technical Sentiment Signal: Buy
Current Market Cap: 45.98B INR
For a thorough assessment of DCAL stock, go to TipRanks’ Stock Analysis page.